Valery Vilchez1, Malay B Shah1, Michael F Daily1, Luis Pena2, Ching-Wei D Tzeng1, Daniel Davenport1, Peter J Hosein3, Roberto Gedaly1, Erin Maynard4. 1. Department of Surgery, University of Kentucky, College of Medicine, Lexington, KY, 40536, USA. 2. Department of Gastroenterology, University of Kentucky, Lexington, KY, 40536, USA. 3. Department of Internal Medicine, University of Kentucky, Lexington, KY, 40536, USA. 4. Department of Surgery, University of Kentucky, College of Medicine, Lexington, KY, 40536, USA. Electronic address: erin.maynard@uky.edu.
Abstract
BACKGROUND: Mixed hepatocellular and cholangiocarcinoma (HCC-CC) have been associated with a poor prognosis after liver transplantation (LT). We aimed to evaluate long-term outcomes in patients undergoing LT for HCC-CC versus patients with hepatocellular carcinoma (HCC) or cholangiocarcinoma (CC). METHODS: Retrospective analysis of the United Network for Organ Sharing (UNOS) database from 1994-2013. Overall survival (OS) in patients with HCC-CC, HCC, and CC, were compared. RESULTS: We identified 4049 patients transplanted for primary malignancy (94 HCC-CC; 3515 HCC; 440 CC). Mean age of patients with HCC-CC was 57 ± 10 years, and 77% were male. MELD score did not differ among the groups (p = 0.637). Hepatitis C virus was the most common secondary diagnosis within the HCC-CC (44%) and HCC (36%) cohorts, with primary sclerosing cholangitis in the CC (16%) cohort. OS rates at 1, 3 and 5 years for HCC-CC (82%, 47%, 40%) were similar to CC (79%, 58%, 47%), but significantly worse than HCC (86%, 72%, and 62% p = 0.002). DISCUSSION: Patients undergoing LT for HCC had significantly better survival compared to those transplanted for HCC-CC and CC. LT for mixed HCC-CC confers a survival rate similar to selected patients with CC. Efforts should be made to identify HCC-CC patients preoperatively.
BACKGROUND: Mixed hepatocellular and cholangiocarcinoma (HCC-CC) have been associated with a poor prognosis after liver transplantation (LT). We aimed to evaluate long-term outcomes in patients undergoing LT for HCC-CC versus patients with hepatocellular carcinoma (HCC) or cholangiocarcinoma (CC). METHODS: Retrospective analysis of the United Network for Organ Sharing (UNOS) database from 1994-2013. Overall survival (OS) in patients with HCC-CC, HCC, and CC, were compared. RESULTS: We identified 4049 patients transplanted for primary malignancy (94 HCC-CC; 3515 HCC; 440 CC). Mean age of patients with HCC-CC was 57 ± 10 years, and 77% were male. MELD score did not differ among the groups (p = 0.637). Hepatitis C virus was the most common secondary diagnosis within the HCC-CC (44%) and HCC (36%) cohorts, with primary sclerosing cholangitis in the CC (16%) cohort. OS rates at 1, 3 and 5 years for HCC-CC (82%, 47%, 40%) were similar to CC (79%, 58%, 47%), but significantly worse than HCC (86%, 72%, and 62% p = 0.002). DISCUSSION: Patients undergoing LT for HCC had significantly better survival compared to those transplanted for HCC-CC and CC. LT for mixed HCC-CC confers a survival rate similar to selected patients with CC. Efforts should be made to identify HCC-CC patients preoperatively.
Authors: C Panjala; D L Senecal; M D Bridges; G P Kim; R E Nakhleh; J H H Nguyen; D M Harnois Journal: Am J Transplant Date: 2010-05 Impact factor: 8.086
Authors: Ki Hun Kim; Sung Gyu Lee; Eun Hwa Park; Shin Hwang; Chul Soo Ahn; Deok Bog Moon; Tae Yong Ha; Gi Won Song; Dong Hwan Jung; Kang Mo Kim; Young Suk Lim; Han Chu Lee; Young Hwa Chung; Yung Sang Lee; Dong Jin Suh Journal: Ann Surg Oncol Date: 2009-01-06 Impact factor: 5.344
Authors: Jane E Rogers; Ryan M Bolonesi; Asif Rashid; Khaled M Elsayes; Mohamed G Elbanan; Lindsey Law; Ahmed Kaseb; Rachna T Shroff Journal: J Gastrointest Oncol Date: 2017-04
Authors: Daniel R Ludwig; Tyler J Fraum; Roberto Cannella; David H Ballard; Richard Tsai; Muhammad Naeem; Maverick LeBlanc; Amber Salter; Allan Tsung; Anup S Shetty; Amir A Borhani; Alessandro Furlan; Kathryn J Fowler Journal: Abdom Radiol (NY) Date: 2019-06
Authors: John R Bergquist; Ryan T Groeschl; Tommy Ivanics; Christopher R Shubert; Elizabeth B Habermann; Michael L Kendrick; Michael B Farnell; David M Nagorney; Mark J Truty; Rory L Smoot Journal: HPB (Oxford) Date: 2016-08-18 Impact factor: 3.647
Authors: Thomas T DeLeon; Marcela A Salomao; Bashar A Aqel; Mohamad B Sonbol; Raquel T Yokoda; Ahmad H Ali; Adyr A Moss; Amit K Mathur; David M Chascsa; Jorge Rakela; Alan H Bryce; Mitesh J Borad Journal: J Gastrointest Oncol Date: 2018-12